Press Releases

Monday, July 16, 2018
The Herd of Hope campaign will raise funds for critical cancer research while building civic pride.
The cancer center is one of the first in the country to receive this designation
Tuesday, June 26, 2018
Roswell Park Comprehensive Cancer Center has been recognized for the superior care it offers cancer patients, having been named one of the first Blue Distinction® Centers for Cancer Care. The center is one of four hospitals in New York State, and 42 nationwide that received this designation.
Two organizations, collaborating since 2016, to expand oncology services in Oneida
Tuesday, June 26, 2018
Roswell Park Comprehensive Cancer Center and Oneida Healthcare have marked two milestones: the full implementation of a new medical oncology facility and ground-breaking at the site of a state-of-the-art radiation oncology center on the same campus. Both developments are part of a collaborative initiative to provide increased local access to the services of a National Cancer Institute-designated comprehensive cancer center to residents of Central New York.
Monday, June 25, 2018
David Scott, who serves as Director of Diversity and Inclusion at Roswell Park, was surprised with the Lighthouse of Partners Award at the FruitBelt Coalition’s 8th Annual Recognition Banquet earlier this month.
Saturday, June 23, 2018
A rainy forecast didn’t deter the thousands of riders who rolled up to The Ride For Roswell start lines at the University at Buffalo (UB) and Roswell Park.
Tuesday, June 19, 2018

BUFFALO, N.Y. — Roswell Park’s Marketing/Creative Services team received two international and six national awards for excellence in video production and storytelling. They were honored for two videos that were conceptualized, written and created in-house.

Thursday, June 14, 2018
The American Cancer Society has awarded a $792,000 multi-year research grant to John Ebos, PhD, of the Department of Pharmacology and Therapeutics at Roswell Park. Patients with metastatic kidney cancer often stop treatment when the tumor becomes resistant to the drugs they are receiving. In many cases, the tumor can immediately begin to grow again. Dr. Ebos is studying a vaccine to inhibit the tumor growth that often happens when treatment has stopped, providing much-needed time to identify new treatment options for the patient.
Thursday, June 7, 2018
In a new study published today in PLOS Genetics, Christine Ambrosone, PhD, of Roswell Park Comprehensive Cancer Center and colleagues identified a genetic difference between people with African and European ancestry that affects how the immune system triggers inflammation. They suspect these differences are rooted in how the immune system evolved and the evolutionary pressure exerted by malaria on ancestors who lived in Africa.
Friday, June 1, 2018
Roswell Park Comprehensive Cancer Center researchers have identified significant differences in the immune microenvironment of breast cancer tumors between African-American and white women, shedding light on the ways in which race can influence cancer development and outcomes.
Friday, June 1, 2018

CHICAGO — Research from Roswell Park Comprehensive Cancer Center suggests that a new treatment combination can extend survival for many patients with advanced colorectal cancer.

Thursday, May 31, 2018
Former Disney executive, Bryan Wittman, and his wife Kathy will serve as Chairmen of the 2018 Roswell Park Comprehensive Cancer Center’s 28th annual All Star Night – the institute’s signature black-tie event taking place on Saturday, November 10, 2018, at the Buffalo Niagara Convention Center.
Thursday, May 31, 2018
Roswell Park Comprehensive Cancer Center has been approved to administer Kymriah. It’s the first FDA-approved CAR T-cell therapy that’s designed to help a patient’s immune system fight cancer. The cutting-edge treatment is also breaking ground as the first CAR T-cell therapy approved by the FDA to treat two types of cancer, lymphoma and leukemia.